INSILICO MEDICINE Trademark

Trademark Overview


On Wednesday, August 17, 2022, a trademark application was filed for INSILICO MEDICINE with the United States Patent and Trademark Office. The USPTO has given the INSILICO MEDICINE trademark a serial number of 97552528. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 20, 2024. This trademark is owned by Insilico Medicine IP Limited. The INSILICO MEDICINE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of fibrosis, oncology, immunology, anti-infectious, central nervous system related and other diseases and disorders; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Biological preparations for the treatment of cancer for medical purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for treating fibrosis, oncology, immunology, anti-infectious, central nervous system related and other diseases and disorders; diagnostic preparations for medical purposes; dietary supplements for human beings; Dietetic foods and beverages adapted for medical use; adjuvants for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Medicinal preparations for the mouth to be applied in the form...
insilico medicine

General Information


Serial Number97552528
Word MarkINSILICO MEDICINE
Filing DateWednesday, August 17, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, February 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of fibrosis, oncology, immunology, anti-infectious, central nervous system related and other diseases and disorders; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Biological preparations for the treatment of cancer for medical purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for treating fibrosis, oncology, immunology, anti-infectious, central nervous system related and other diseases and disorders; diagnostic preparations for medical purposes; dietary supplements for human beings; Dietetic foods and beverages adapted for medical use; adjuvants for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Medicinal preparations for the mouth to be applied in the form of capsules; Pharmaceutical and biological preparations for the treatment of fibrosis, oncology, immunology, anti-infectious, central nervous system related and other diseases and disorders and cancer for medical purposes
Disclaimer with Predetermined Text"MEDICINE"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 7, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameInsilico Medicine IP Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCentral 999077
HK

Party NameInsilico Medicine IP Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCentral
HK

Trademark Events


Event DateEvent Description
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 20, 2024PUBLISHED FOR OPPOSITION
Thursday, February 1, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 1, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 31, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, January 12, 2024CASE RETURNED TO EXAMINATION
Friday, January 12, 2024NOTICE OF ALLOWANCE CANCELLED
Friday, December 8, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Friday, December 8, 2023PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Thursday, December 7, 2023ASSIGNED TO PETITION STAFF
Monday, November 13, 2023TEAS PETITION TO AMEND BASIS RECEIVED
Thursday, November 9, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, November 9, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 9, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, November 9, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 9, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 9, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 9, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 7, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 12, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 12, 2023PUBLISHED FOR OPPOSITION
Wednesday, August 23, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 26, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, July 26, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 26, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, July 26, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 13, 2023COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Tuesday, June 13, 2023ASSIGNED TO LIE
Wednesday, June 7, 2023NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, June 7, 2023EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Wednesday, June 7, 2023EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Saturday, May 20, 2023ASSIGNED TO EXAMINER
Wednesday, September 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 20, 2022NEW APPLICATION ENTERED